# 视角幻觉

[◀返回](./home.html)

**视角幻觉**（Perspective hallucination）嘛，就是通过某种视角看到既定的[内在幻觉](/FreeODwiki/药效/内在幻觉.html)或[外在幻觉](/FreeODwiki/药效/外在幻觉.html)时的改变哦。

这种效应能够以下面描述的四种不同视角表现出来呢：

*   **第一人称** - 最常见的视角形式，可以描述为从这个人日常的自我和身体感知幻觉的正常体验。
*   **第二人称** - 这种视角可以描述为从外部意识来源（比如另一个人、动物或无生命的物体）的视点感知幻觉的体验呢。
*   **第三人称** - 这种视角可以描述为一种出体体验，其中一个人的视点漂浮在他们肉体的上方、下方、后方或前方。
*   **第四人称** - 最不常见的视角形式，可以描述为同时从多个甚至看似无限的视点和角度感知幻觉的体验，好神奇的喵！

视角幻觉通常伴随着其他同时发生的效应，比如[谵妄](/FreeODwiki/药效/谵妄.html)和[记忆抑制](/FreeODwiki/药效/记忆抑制.html)。它们最常在[致幻剂](/FreeODwiki/文档/药物分类/致幻剂.html)类化合物（如[迷幻剂](/FreeODwiki/文档/药物分类/迷幻剂.html)、[解离剂](/FreeODwiki/文档/药物分类/解离剂.html)和[谵妄剂](/FreeODwiki/文档/药物分类/谵妄剂.html)）的[严重](/FreeODwiki/文档/药物剂量分类.html#严重)[剂量](/FreeODwiki/文档/药物剂量分类.html)影响下被诱发。

<!-- 请勿删除或修改，这是一个标记，待识别并填坑（药效索引） -->

### 体验报告

在我们的[体验索引](/FreeODwiki/文档/体验索引.html)中，描述这种效应的轶事报告包括：

*   [Experience: 25mg 2C-E (oral) - A mindblowing experience](/FreeODwiki/报告/psychounautwiki/Experience:_25mg_2C-E_(oral)_-_A_mindblowing_experience)
*   [Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective](/FreeODwiki/报告/psychounautwiki/Experience:3_Grams_of_Mushrooms_-_Reset_on_my_Life,_Experiencing_Satori_and_the_Cosmic_Perspective)
*   [Experience:40mg - Brothermind and the Forest's Hand](/FreeODwiki/报告/psychounautwiki/Experience:40mg_-_Brothermind_and_the_Forest%27s_Hand)
*   [Experience:DMT (unknown dose, smoked) - It felt like I was on rails the whole time](/FreeODwiki/报告/psychounautwiki/Experience:DMT_(unknown_dose,_smoked)_-_It_felt_like_I_was_on_rails_the_whole_time)
*   [Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death](/FreeODwiki/报告/psychounautwiki/Experience:Unknown_Dose_DOC_(Insufflated)_-_Overdosing_and_Terifying_Ego_Death)

### 另见

*   [负责任的用药索引页](/FreeODwiki/文档/负责任的用药索引页.html)
*   [主观效应索引](/FreeODwiki/药效/home.html)
*   [透视扭曲](/FreeODwiki/药效/透视扭曲.html)
*   [谵妄剂 - 主观效应](/FreeODwiki/文档/药物分类/谵妄剂.html#主观效应)
*   [迷幻剂 - 主观效应](/FreeODwiki/文档/药物分类/迷幻剂.html#主观效应)
*   [解离剂 - 主观效应](/FreeODwiki/文档/药物分类/解离剂.html#主观效应)

### 参考文献

1.  ↑ [1.0](#cite_ref-Dillon2003_1-0) [1.1](#cite_ref-Dillon2003_1-1) Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". *Drug and Alcohol Dependence*. **69** (1): 23–28. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/S0376-8716(02)00243-0](/FreeODwiki//doi.org/10.1016%2FS0376-8716%2802%2900243-0). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) 0376-8716.
2.  ↑ [2.0](#cite_ref-ObreshkovaKandilarov2017_2-0) [2.1](#cite_ref-ObreshkovaKandilarov2017_2-1) Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. <http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf>
3.  ↑ [3.0](#cite_ref-Jansen1990_3-0) [3.1](#cite_ref-Jansen1990_3-1) Jansen, K.L.R. (1990). "Neuroscience and the Near-Death Experience: Roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins". *Medical Hypotheses*. **31** (1): 25–29. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/0306-9877(90)90048-J](/FreeODwiki//doi.org/10.1016%2F0306-9877%2890%2990048-J). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) 0306-9877.
4.  ↑ [4.0](#cite_ref-Rumpf1969_4-0) [4.1](#cite_ref-Rumpf1969_4-1) Rumpf K, Pedeck J, Teuteberg H. Munchhoff W. Nolte H. Dream-like experiences during brief anaesthesia with ketamine. thiopental and propanidid. p 161 in Ketamine (H Kreuscher. ed.) Springer-Verlag. Berlin, 1969.
5.  ↑ [5.0](#cite_ref-Siegel1978_5-0) [5.1](#cite_ref-Siegel1978_5-1) Siegel R K. Phencyclidine and ketamine intoxication: a study of recreational users. p 119 in Phencyclidine Abuse: An Appraisal (R C Peterson. R C Stillman. eds.). National Institute on Drug Abuse Research Monograph 21. NIDA. Rockville. Maryland, 1978.
6.  [↑](#cite_ref-WilkinsGirard2011_6-0) Wilkins, Leanne K.; Girard, Todd A.; Cheyne, J. Allan (2011). "Ketamine as a primary predictor of out-of-body experiences associated with multiple substance use". *Consciousness and Cognition*. **20** (3): 943–950. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/j.concog.2011.01.005](/FreeODwiki//doi.org/10.1016%2Fj.concog.2011.01.005). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number) 1053-8100.
7.  [↑](#cite_ref-7) Przyby, A. (n.d.). A Philosophical Journey into the Heart of the Psychedelic Dream. Chicago, IL: University of Chicago. Retrieved February 24, 2018, from <http://midwayreview.uchicago.edu/a/8/3/przybyl/przybyl.pdf>